Gossamer Bio's total assets for Q4 2025 were $172.25M, a decrease of -17.51% from the previous quarter. GOSS total liabilities were $295.01M for the fiscal quarter, a 1.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.